Unlike many solid cancers where new targeted therapies that are coming out every day, progress in AML has been extremely sluggish, until recently
Center will have an open process for granting access to physicians
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: